Ponsegromab increased weight and activity levels in cachexia patients, confirming GDF-15 as a key driver and therapeutic target. Significant weight gain was observed in ponsegromab-treated groups ...
MedPage Today on MSN
Regular physical activity thwarts fatigue, boosts QoL in colorectal cancer
Strongest, most consistent signal of benefit with walking, but only in nonmetastatic CRC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results